<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/780878F1-19F5-499D-AF2B-D90BA40DBF65"><gtr:id>780878F1-19F5-499D-AF2B-D90BA40DBF65</gtr:id><gtr:name>NHS Bradford City CCG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1214CB60-959A-4B69-9BF0-585BD6627832"><gtr:id>1214CB60-959A-4B69-9BF0-585BD6627832</gtr:id><gtr:name>NHS Sheffield CCG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F"><gtr:id>9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F</gtr:id><gtr:name>University of Bradford</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/780878F1-19F5-499D-AF2B-D90BA40DBF65"><gtr:id>780878F1-19F5-499D-AF2B-D90BA40DBF65</gtr:id><gtr:name>NHS Bradford City CCG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1214CB60-959A-4B69-9BF0-585BD6627832"><gtr:id>1214CB60-959A-4B69-9BF0-585BD6627832</gtr:id><gtr:name>NHS Sheffield CCG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A97A8EC9-C79E-4701-BC21-6F259E0C8AE9"><gtr:id>A97A8EC9-C79E-4701-BC21-6F259E0C8AE9</gtr:id><gtr:name>Oslo University Hospital</gtr:name><gtr:address><gtr:line1>Ullevaal</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F"><gtr:id>9FF42FA0-E5E6-4CD8-870A-2C1E5055F52F</gtr:id><gtr:name>University of Bradford</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/828B44A0-5E5A-4D41-8BA6-25B7CA0C77A2"><gtr:id>828B44A0-5E5A-4D41-8BA6-25B7CA0C77A2</gtr:id><gtr:firstName>Alasdair</gtr:firstName><gtr:otherNames>Maurice</gtr:otherNames><gtr:surname>MacLullich</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F646"><gtr:id>981C9D05-3D84-4A3F-B246-8A85DD8CCBA6</gtr:id><gtr:title>The Role of Dysregulation of Glucocortoids in the onset, Course and outcome of Delirium in the older people</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/646</gtr:grantReference><gtr:abstractText>Acute confusion commonly occurs in older people, and especially in patients with dementia, with acute illness and after operations. Until recently, doctors thought that acute confusion was unimportant. Thus, few specific treatments are available, and almost nothing is known about the causes. However, acute confusion is now known to be potentially serious, being linked with longer stays in hospital, other illnesses, and long-term permanent memory problems. Because of this, urgent research is now needed.
 
Experimental studies have shown that high levels of the hormone cortisol can cause confusion. Cortisol goes up in illness and after surgery. In old age it often stays high for too long, and therefore possibly causing confusion.
 
In this study, 200 older people awaiting surgery will have tests of cortisol and memory, and will have brain scans. After surgery we expect that about 40 people will become confused, and we will test to see if this is linked with high cortisol, using memory tests and repeat brain scans.

If high cortisol is linked with acute confusion, new treatments, such as anti-cortisol drugs, will be developed. Because thousands of older people become acutely confused every year in the UK, any new treatments would be of great benefit.</gtr:abstractText><gtr:technicalSummary>AIMS: Delirium (acute confusional state) is a highly prevalent, serious, and poorly understood acute condition, occurring mainly in older people. The main cognitive deficit is in attention. Associated with acute illness, trauma, or certain drugs, delirium is an independent predictor of increased length of stay, morbidity, institutionalisation, and mortality. Moreover, episodes of delirium may be a marker of brain pathology, or cause brain damage, because in patients matched for cognitive function, those suffering an episode of delirium have a higher risk of dementia 1-2 years later. 
 The mechanisms are poorly understood, but one important hypothesis is that pathologically sustained high glucocorticoid (GC) levels occurring in the context of acute physiological stress is involved in delirium. Supporting evidence includes the observation that ageing is associated with failure to suppress cortisol levels after a stressor because of defective feedback regulation. Therefore, some older people will show inappropriately sustained high glucocorticoids (GCs) in the context of stress (acute illness, surgery, etc.). Also, sustained high GCs cause attentional deficits, probably related to prefrontal cortical dysfunction; deficits in declarative memory and hippocampal dysfunction are also consequences of high GCs. 
OBJECTIVES: (1) determine if higher cortisol levels after a pre-operative dexamethasone suppression test predict a higher risk of delirium; (2) determine if delirium in association with high GCs is associated with (a) permanent decrements in cognitive function, and (b) permanent structural and biochemical alterations in the brain.
DESIGN: Prospective natural history study of 200 patients aged over 70 undergoing elective orthopaedic surgery. 
METHODOLOGY: 200 patients undergoing major elective orthopaedic surgery will have pre-operative (1-2 months) detailed measurements of GC levels, including post-dexamethasone cortisol; cognitive assessment; detailed neuroimaging, including subregional volumes (prefrontal cortex, hippocampus, etc.), diffusion tensor imaging, and magnetic resonance spectroscopy. Peri-operatively patients will be assessed for delirium and GC levels will be measured. Three months post-operatively, cognitive assessment will be performed in all patients, and neuroimaging in 25 patients who have had delirium, and 25 controls.
SCIENTIFIC AND MEDICAL OPPORTUNITIES: Delirium imposes an enormous human and socioeconomic burden, and is a major unmet medical need. It has been subjected to strikingly little mechanistic research. Should impaired regulation of glucocorticoid levels be a major mechanism of delirium, this will open the door to further focused mechanistic research, and medically, preventive and treatment (eg. anti-glucocorticoids) strategies. Reductions of even a few percent in the incidence, severity, or duration of delirium would have large health and economic benefits.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>815341</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oslo University Hospital</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Geriatric Medicine</gtr:department><gtr:description>Cerebrospinal fluid analyses in delirium: University of Oslo</gtr:description><gtr:id>7B9589E7-FFB9-46A3-9BF7-67AD9D8AB900</gtr:id><gtr:impact>Poster presentations in the American Delirium Society meeting in Indianapolis in June 2011. One poster presentation in the European Delirium Association meeting in Nov 2011. The collaboration is multidisciplinary, involving basic laboratory science and clinical geriatric medicine.


Additional findings were presented at the American Delirium Society meeting in June 2012, and the European Delirium Society in Oct 2012.</gtr:impact><gtr:outcomeId>s7isnmYqYea-1</gtr:outcomeId><gtr:partnerContribution>We have received and sent cerebrospinal fluid samples from each other's cohorts and performed different sets of analyses on these samples.</gtr:partnerContribution><gtr:piContribution>We initiated this collaboration, to share samples and analyses. We contributed information about methodology.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bradford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>F5F55DDD-5481-4D44-9A09-8DC24CACED51</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-3</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Cognitive Ageing and Cognitive Epidemiology</gtr:department><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>EA562C88-4155-4623-8946-6ED94D2C0F50</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-2</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Lothian</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Liaison Psychiatry</gtr:department><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>A2A035CB-1FD2-4CD3-AFE4-24C663AA4FF0</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-1</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Psychology</gtr:department><gtr:description>Neuropsychological testing in delirium</gtr:description><gtr:id>0D633393-79F7-4FE6-95CC-848BD760F1E3</gtr:id><gtr:impact>New grant: 'Development of a new neuropsychological instrument for the diagnosis and monitoring of delirium'. This has led to new grants (&amp;pound;150,000 from the MRC Development Pathway Funding Scheme, then a further &amp;pound;1.06M from the same scheme). The device is known as the Delbox, and a software version called the DelApp. . The project has so far multiple papers at international conferences and research papers. The DelBox and DelApp are being used in our own studies but also in other studies, eg. the LUCID study in Oslo, and a study in John Hopkins.</gtr:impact><gtr:outcomeId>2C36C520631-1</gtr:outcomeId><gtr:partnerContribution>Involvement in neuropsychology of delirium projects; consultation on cognitive test design, recruitment of dementia patients, statistical analyses</gtr:partnerContribution><gtr:piContribution>Experimental design in neuropsychology of delirium projects</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Development of a new animal model of delirium based on the spontaneously hypertensive rat</gtr:description><gtr:id>21864D87-2298-48C8-997E-C76CECD9CD5E</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>j8WDRxoi7o8-1</gtr:outcomeId><gtr:partnerContribution>Dr Colm Cunningham (Wellcome Trust Senior Research Fellow) has provided training and advice for members of the team, and has contributed to the experimental design.</gtr:partnerContribution><gtr:piContribution>I initiated this work. It involves several University of Edinburgh collaborators, from basic science to neuroimaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute of Public Health</gtr:department><gtr:description>Delirium epidemiology</gtr:description><gtr:id>FF7209DD-D2E9-4186-932A-92977E99BAF9</gtr:id><gtr:impact>Manuscript in submission. Oral presentation (by Dr Daniel Davis, University of Cambridge) at European Delirium Association meeting in Umea, Sweden, Nov 2011.

The main paper from the first set of analyses has been published in the journal Brain.</gtr:impact><gtr:outcomeId>WtejhREozgn-1</gtr:outcomeId><gtr:partnerContribution>Added knowledge on how delirium alters trajectories of cognitive decline and neuropathological findings.</gtr:partnerContribution><gtr:piContribution>I have contributed to the generation of the idea to study delirium's impact on cognitive trajectories, interpretation of data, study design and writing of the manuscript</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Sheffield CCG</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>0E947C46-A75F-4160-9E60-35A03E2E581D</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-6</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Internal Medicine</gtr:department><gtr:description>Cerebrospinal fluid analyses in delirium: University of Amsterdam</gtr:description><gtr:id>F47D14A1-1A91-4593-8B20-FCDA03422446</gtr:id><gtr:impact>Two abstracts at the European Delirium Association meeting, Nov 2010 (both oral presentations). One paper published in the Journal of the American Geriatrics Society. Two further papers in progress. Adoption of the CSF sampling during spinal anaesthesia by several other groups.</gtr:impact><gtr:outcomeId>LznDa1wVqKb-1</gtr:outcomeId><gtr:partnerContribution>We have shared protocols and we analysed cerebrospinal fluid in patients with delirium collected in the Netherlands. We have presented the work at the European Delirium Association and are about to submit two papers on this.</gtr:partnerContribution><gtr:piContribution>We are the leaders of the project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Bradford City CCG</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>EAAB6D87-7C4E-43DA-9B9B-CE41D40B034D</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-5</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Emergency Medicine</gtr:department><gtr:description>Development of a new brief clinical screening tool for delirium and cognitive impairment: the 4AT</gtr:description><gtr:id>0C631353-89D9-4E6C-A611-E6A1583A1AF2</gtr:id><gtr:impact>We have written a new test called the 4AT. This instrument is now in clinical use in several clinical settings in NHS Lothian and elsewhere in the UK, and internationally. The test is available at this website: www.the4AT.com.

A grant validating the 4AT was awarded by the NIHR and studies are ongoing. The first part of the study has yielded valuable information on implementation of the detection tool.</gtr:impact><gtr:outcomeId>sJSFReBEDVA-4</gtr:outcomeId><gtr:partnerContribution>Expertise in liaison psychiatry, eg. delirium diagnosis, and design of tool evaluation procedures.Statistical support and access to volunteer and patient cohorts. Three-site study now running.</gtr:partnerContribution><gtr:piContribution>I initiated this project, by first writing the 4AT with two colleagues (Tracy Ryan and Helen Cash) and then forming a network of collaborators to test the properties of the instrument.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk on delirium to UK Brussels Office</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EDF1D621-E510-4585-8EFD-0667E2CF541F</gtr:id><gtr:impact>I spoke on delirium research at a meeting of UK regional health offices on ageing issues in health which was hosted by the the UK Brussels Office. This was on Jun 5 2009

Ongoing contacts with policymakers</gtr:impact><gtr:outcomeId>EFBE657F104</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4AT website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>47537CCA-D2F7-400C-AC8A-5F5C370A9FB1</gtr:id><gtr:impact>I set up the website www.the4AT.com in 2011. This website allows for the dissemination of the delirium detection the 4 &amp;quot;A&amp;quot;s Test (4AT) that I wrote (with two colleagues) in 2011. It also provides some background information on the 4AT.

Since 2011, the 4AT website has had increasing traffic. In the year to March 11 2017, it had 60,000 visits from 25,000 users. These users are global, with most visit from the UK, Australia, and the USA.</gtr:impact><gtr:outcomeId>58c4fd15efb275.01327598</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.the4AT.com</gtr:url><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Health Improvement Scotland - ongoing meetings and changes to clinical practice recommendations</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53933B1E-FA62-4579-8BC8-79029E483CAD</gtr:id><gtr:impact>I have an ongoing partnership with Healthcare Improvement Scotland (Scottish Government Health Department) which involves producing materials related to delirium detection (4AT: www.the4AT.com), delirium treatment (the TIME bundle and the summary and comprehensive delirium management pathways), and a new initiative related to delirium prevention. 

The impacts have been extensive, with this partnership producing materials now in wide clinical use in dozens of UK hospitals, and also used internationally (eg. in 5 hospitals in Houston, Texas).

I received several requests for my presentation slides. These slides will also be made available on NHS websites.

The talk also generated publicity for the Scottish Delirium Association (www.scottishdeliriumassociation.com) which I co-founded in 2010 to provide a forum for sharing of pathways, teaching resources, research findings, audit methodologies, etc.</gtr:impact><gtr:outcomeId>gvjGui1QbUm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.scottishdeliriumassociation.com</gtr:url><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Audio podcast on delirium detection for the BMJ Group (posted Nov 14 2011)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F1B523C5-2AC4-4203-8FC9-5A5E02E3079C</gtr:id><gtr:impact>The podcast is on a public website. It was posted on 14 Nov. By 2 Dec it had had 450 downloads.

Unknown at this stage.</gtr:impact><gtr:outcomeId>GXbGGxQLK8Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dissemination of information on new 4AT screening instrument for delirium and cognitive impairment: incorporation into NHS Education for Scotland dementia education</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20F18FB1-D880-4950-9C1F-49956BE9F4BE</gtr:id><gtr:impact>The 4AT is included in national educational materials in this website: http://www.nes.scot.nhs.uk/media/350872/acute_dementia_interactive_2011.pdf

The 4AT is also part of Healthcare Improvement Scotland's 'Delirium Toolkit': http://www.healthcareimprovementscotland.org/our_work/person-centred_care/opac_improvement_programme/delirium_toolkit.aspx

The 4AT is a new screening instrument for delirium and cognitive impairment which is being used in various NHS settings across the UK.</gtr:impact><gtr:outcomeId>BkCRA3e4RB1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.the4AT.com</gtr:url><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple lectures on the 4AT to clinical audiences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B60C1DC8-5566-46B7-90F9-422136B8FA6A</gtr:id><gtr:impact>Multiple lectures locally, nationally and internationally to clinical audiences on the 4AT. More than 1000 attendees. Active website which now has &amp;gt;800 hits per month. 4AT now implemented as a routine clinical for delirium detection in multiple UK hospitals, and several international sites.

The 4AT is implemented on several wards locally and is being trialled in sites around the UK and elsewhere.</gtr:impact><gtr:outcomeId>DgsrCyYSPy1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.the4AT.com</gtr:url><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Council invited talk, Spain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>75FF7FDC-20E1-405C-B3BC-015B05D462E4</gtr:id><gtr:impact>I gave a talk in Seville on Nov 6th 2009 sponsored by the British Council, the Instituto Tomas Pascal and the Fundacion de Ciencias de la Salud, entitled, &amp;quot;Delirium and dementia: recent advances and future developments&amp;quot;. The audience was primarily lay.

The impacts were some reports in the Spanish press. I also did an associated radio interview for 'Radio Exterior de Espa&amp;ntilde;a' which will be broadcast in the next few weeks.</gtr:impact><gtr:outcomeId>8C5C2B8B3FB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCPE talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>321890D5-02DB-4E48-8522-59B2F8725419</gtr:id><gtr:impact>I received several requests for my talk slides.

The event was on 30 October 2012.

This talk contributed to the increasing interest in delirium, and specifically in exposure of the screening instrument the 4AT.</gtr:impact><gtr:outcomeId>ZXDno2GkBcZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV interviews: BBC Scotland and STV</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AB125D00-AA74-4743-AC0F-862A4B256639</gtr:id><gtr:impact>I contributed to a press release and was interviewed by BBC Scotland and STV relating to a 'Hot Topics Symposium' on 'The Confused Patient in the Acute Hospital' that I initiated and organised at the Royal College of Physicians of Edinburgh. The TV interviews appeared on the evening news and the TV station websites, and the press release was widely cited in the Scottish press.

I was invited by a BBC Scotland reporter to get in contact about a possible longer piece on delirium.</gtr:impact><gtr:outcomeId>pv96QmoruJ5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>185751</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:fundingRef>R484/0516</gtr:fundingRef><gtr:id>A8B76644-50E5-40FF-877A-A20DB9D02FD9</gtr:id><gtr:outcomeId>58c4f27ea6c649.57068880</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1007984</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS/DCS</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>L023210/1</gtr:fundingRef><gtr:id>749DC5AB-EEB2-43C1-A37D-BCA1607F6F62</gtr:id><gtr:outcomeId>545292ea34bef9.07378995</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>193181</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO Research Grant</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>F4170EB0-BAA5-4036-94C5-1F1EBE158BAF</gtr:id><gtr:outcomeId>1C286CFB56E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dunhill Medical Trust Clinical Research Fellowship</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:id>DB88AB95-FEA1-495C-9AE4-16F8ADDE5E1D</gtr:id><gtr:outcomeId>GUoEhwpwN9a0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245168</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research into Ageing Fund (RiAF)</gtr:department><gtr:description>Clinical Research Fellowship</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Age UK</gtr:fundingOrg><gtr:id>2C66D024-DE73-4C2C-B4C2-0DC0E0C4DA57</gtr:id><gtr:outcomeId>740B63B1B5F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NHS Education for Scotland funding</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>NHS Health Scotland</gtr:fundingOrg><gtr:id>EEA757FB-1C7A-4E62-9877-4524A5911B4F</gtr:id><gtr:outcomeId>JyDkEvq8Rni0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC funding (Targetted Priority Studentships Programme)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>99113A5A-59BB-423D-99CE-7728D72892FF</gtr:id><gtr:outcomeId>30E6E4887F40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>260000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PG2016B-12</gtr:fundingRef><gtr:id>983342EB-A8E7-44F1-A2A9-AC76F1477556</gtr:id><gtr:outcomeId>58c4393edc97c6.43122000</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>819726</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HTA</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>11/143/01</gtr:fundingRef><gtr:id>32451118-F620-4A57-9497-BBE478C92003</gtr:id><gtr:outcomeId>j5tfx5M6WqS</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>190000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>E-007</gtr:fundingRef><gtr:id>5ED922A9-5A98-43EA-8AE9-F420BEE9D4BD</gtr:id><gtr:outcomeId>0363D7C50F10</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Age UK</gtr:fundingOrg><gtr:id>0610D544-5B64-4DD6-87AC-11156043339A</gtr:id><gtr:outcomeId>JcZJinZBmL4</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>AD199958-9AB7-4A0B-B3FE-2F05756AA3A3</gtr:id><gtr:outcomeId>Mi1P97hgNEA</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A new computerised neuropsychological testing device with novel cognitive testing procedures for the assessment of attentional deficits in delirium.</gtr:description><gtr:grantRef>G108/646</gtr:grantRef><gtr:id>5C1754B9-C596-4C46-B471-517295359E26</gtr:id><gtr:impact>A grant (&amp;pound;150,000) from the MRC DPFS scheme to commercialise the device.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>D9645BEE4D7</gtr:outcomeId><gtr:patentId>EP2485645</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>A new computerised instrument for detection of attentional deficits in delirium</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Founded European Delirium Association</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5B563B0D-F3CE-4AEC-A305-FEBF44AD9EC6</gtr:id><gtr:impact>The EDA is the world's first international organisation focused on delirium. It now has 300 members and has held 4 international conferences (The Netherlands, Ireland, Finland, England). We have developed standards for research which have influenced many researchers, and also have clinical guidelines and educational materials on our website which have been downloaded by users in many different countries.</gtr:impact><gtr:outcomeId>4BF21C5F84A</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of regional group: 'Delirium and dementia implementation group' (Lothian Health Board)</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>0C31DF0B-2303-474F-A72E-D9D83D2F740D</gtr:id><gtr:impact>Regional group which is responsible for implementing improvements in the detection, management and follow-up of delirium and dementia in the acute general hospitals in my region. This involves multiple educational activities alongside audit.</gtr:impact><gtr:outcomeId>3D2C9D7CC9C</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of Scottish Intercollegiate Guidelines Network - Delirium Guideline</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D3EAEF7A-50BA-4049-B15D-866C2D477BA9</gtr:id><gtr:outcomeId>58c4fed456a157.10381730</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.sign.ac.uk/pdf/Delirium_KQs_v0%203_consultation.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in systematic review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>14D12DA2-BC0E-4A83-8CA5-CE303374C373</gtr:id><gtr:impact>The 4AT delirium assessment tool was included in this systematic review and this has led to increased dissemination and use of the 4AT in clinical practice.</gtr:impact><gtr:outcomeId>58c5037d421e88.87112898</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Delirium adviser on Scottish Govt 'Reshaping Care for Older People' programme</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>D820D6A6-6558-4CB2-B281-F48E9FBA1A7F</gtr:id><gtr:impact>My written contribution has been included in a ministerial review of health service provision in all Scottish health boards.</gtr:impact><gtr:outcomeId>8B17A93D1AD</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Co-founded Scottish Delirium Association</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>387D384F-9069-41AF-9F4B-180DF7CA4122</gtr:id><gtr:impact>The Scottish Delirium Association (SDA) is a group of healthcare professionals that meet quarterly to create and disseminate resources aimed at improving delirium care. The SDA has worked with Healhcare Improvement Scotland (HIS) to produce tools such as the TIME bundle and two delirium care pathways. These tools are now used in clinical practice in Scotland and beyond.</gtr:impact><gtr:outcomeId>MYtbnj3ztBm</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.scottishdeliriumassociation.com</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Delirium Association website</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AA55EB61-C586-491C-BC9E-A777974FAD41</gtr:id><gtr:impact>I set up and am the main author of the European Delirium Association website. This has multiple sources of educational material. The website has been accessed 16,650 times since it was set up in May 2009.</gtr:impact><gtr:outcomeId>gV85ry2VD4B</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influenced delirium detection practice in various national and international locations</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5C28B4E2-6616-4F59-A0B4-6431A82852CD</gtr:id><gtr:impact>The delirium detection questionnaire the 4AT (www.the4AT.com) continues to be increasingly implemented clinically in several international sites. Multiple UK sites including Guy's and St Thomas, Aberdeen Royal Infirmary, and internationally, eg. hospitals in Houston, and Johns Hopkins. Translations into French, German, Thai, Italian, Russian, German, Dutch, etc.

The main way the 4AT is disseminated is my website www.the4AT.com, which I set up independently in 2011.</gtr:impact><gtr:outcomeId>56e03d2d0dac41.13594746</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.the4AT.com</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair of Royal College of Physicans Map of Medicine panel on delirium</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F190FA69-F08F-491A-9B18-E6F93767221C</gtr:id><gtr:impact>National guideline available to most UK hospitals via Map of Medicine scheme (sponsored by Royal College of Physicians (London))</gtr:impact><gtr:outcomeId>E8D82ED16BB</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>4AT test for delirium is mentioned in advice for clinicians in multiple documents and websites</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>883A9C40-39D8-4DD9-B3A6-A5890C87B315</gtr:id><gtr:impact>The 4AT is now being used in many UK sites (eg. London, Birmingham, Inverness, Glasgow) as well as international sites. It is included in many local guidelines as well as the Scottish Government's Healthcare Improvement Scotland care package for delirium. The 4AT is the standard tool for delirium assessment in Scotland, and likely the most widely-used in the UK.

The 4AT was included in the Australian Commission on Safety and Quality in Healthcare Delirium Care Standards. It was also recently included in the Best Practice Tariff for Hip Fracture Care in the NHS in England in 2017.

The outcome is that there is are increased rates of delirium detection and therefore the quality of delirium care in the UK and internationally.</gtr:impact><gtr:outcomeId>mwjboyVAwxP</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.va.gov/GERIATRICS/Guide/LongTermCare/Delirium_professionals.asp#</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>A brief screening instrument for delirium and cognitive impairment for clinical use. Available on this website: www.the4AT.com

No specific funding at present. Preliminary data gathered; funding applications in progress.</gtr:description><gtr:id>7C03196E-1C2F-4144-BD34-4CCC6221D78E</gtr:id><gtr:impact>Increase in rates of delirium diagnosis in Lothian University Hospitals Division. &amp;quot;Delirium&amp;quot; in electronic discharge summary 0.6% in Jan 2010; 1.7% in Sep 2011.</gtr:impact><gtr:outcomeId>XVqXcpbELRV</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>4AT screening test for delirium and cognitive impairment</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.the4AT.com</gtr:url><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A very brief screening instrument for delirium and cognitive impairment primarily aimed to be used in clinical practice but also usable as a research tool.</gtr:description><gtr:id>7FF07287-DB77-4C43-8858-0B37629C9950</gtr:id><gtr:impact>The 4AT is being used in local research projects as well as in routine clinical practice. It has been incorporated into the regional 'Unitary Patient Record' for all emergency adult medical admissions. One impact has been that the rates of the term 'delirium' appearing in electronic discharge summaries has increased from 0.6% to 1.7% between Jan 2010 and Sep 2011.

The 4AT has now been adopted by several London hospitals as the standard screening tool for delirium used in the CQUIN dementia screening programme. It is also a mandatory part of the best practice tariff for acute hip fracture care in England.

IN 2013 the 4AT has been adopted by an increasing number of healthcare organisations.</gtr:impact><gtr:outcomeId>iqeERSsphTk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>4AT screening instrument for delirium and cognitive impairment</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:url>http://www.the4AT.com</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new computerised, programmable, battery-powered small device with new neuropsychological test protocols for delirium assessment in hospital inpatients. Validated.</gtr:description><gtr:id>2C25DB19-91F1-47F6-B46B-43CE71931892</gtr:id><gtr:impact>&amp;pound;150,000 grant from the MRC DPFS scheme to develop commercially-viable device, then &amp;pound;1M grant also from the MRC DPFS scheme (ongoing).</gtr:impact><gtr:outcomeId>966165AD2CD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New computerised instrument for the assessment of attentional deficits in delirium</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>37936400-0B28-403B-ABE3-08F24BC8713D</gtr:id><gtr:title>Cortisol levels and the severity and outcomes of acute stroke: a systematic review.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a587978802fbdbdef6b4802f5b7e3cf0"><gtr:id>a587978802fbdbdef6b4802f5b7e3cf0</gtr:id><gtr:otherNames>Barugh AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56e02f2c801772.50803308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93884E9D-9000-4A74-8F05-C0D8832CBCA6</gtr:id><gtr:title>Higher systolic blood pressure is associated with increased water diffusivity in normal-appearing white matter.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82a2f25a3c494f144b9fe7aac6f1374f"><gtr:id>82a2f25a3c494f144b9fe7aac6f1374f</gtr:id><gtr:otherNames>Maclullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>246F3C79354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3698FC3-4C61-4A8A-B6AB-1BCF5AEA79AE</gtr:id><gtr:title>Manganese-enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic administration of MnCl2: hippocampal signal enhancement without disruption of hippocampus-dependent behavior.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61b87cc9505a171ece971d872111e67"><gtr:id>d61b87cc9505a171ece971d872111e67</gtr:id><gtr:otherNames>Jackson SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>VrcynqzStAg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2DBF7D4-6C81-4EBD-82F0-CE88DF9017C4</gtr:id><gtr:title>Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e4331571207bdb8c508865b5048220e"><gtr:id>2e4331571207bdb8c508865b5048220e</gtr:id><gtr:otherNames>Doubal FN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>shbkuHu3adt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A8F6C80-724D-42C2-8310-17D976CD2E40</gtr:id><gtr:title>At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response.</gtr:title><gtr:parentPublicationTitle>Brain, behavior, and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/375e20070a4cab507c3b015aba01aebf"><gtr:id>375e20070a4cab507c3b015aba01aebf</gtr:id><gtr:otherNames>Cunningham C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0889-1591</gtr:issn><gtr:outcomeId>pm_16128_28_22884900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F909E58B-16D9-4700-A264-4681C18E751A</gtr:id><gtr:title>Reduced level of arousal and increased mortality in adult acute medical admissions: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMC geriatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c901e73d8f3952a371678c784cf9510a"><gtr:id>c901e73d8f3952a371678c784cf9510a</gtr:id><gtr:otherNames>Todd A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2318</gtr:issn><gtr:outcomeId>5aa80cddb9c7a7.96448565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E84703B-7EEC-4B01-8B0A-A4C814775C4F</gtr:id><gtr:title>Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61873e852dfee4934a7fbcc4598ec8fd"><gtr:id>61873e852dfee4934a7fbcc4598ec8fd</gtr:id><gtr:otherNames>Hall RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>pm_16128_28_23602305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>655F2273-9759-4CBE-9FDC-0B78B15182E5</gtr:id><gtr:title>Cerebrospinal fluid interleukin-8 levels are higher in people with hip fracture with perioperative delirium than in controls.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ff22e1adc692f91cc17db244a90af"><gtr:id>038ff22e1adc692f91cc17db244a90af</gtr:id><gtr:otherNames>MacLullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn><gtr:outcomeId>YST7abmJQrS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94EE8AF8-9096-462C-85B2-B3417842BC40</gtr:id><gtr:title>Cognitive visual perceptual deficits in patients with delirium.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d41c319558c06c88080ce895c5a59196"><gtr:id>d41c319558c06c88080ce895c5a59196</gtr:id><gtr:otherNames>Brown LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>BB11B3D878A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0D5DC0F-EA7A-4C3D-AFA0-5438308FAF97</gtr:id><gtr:title>Neuroimaging studies of delirium: a systematic review.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f095c2a425effc4410c61fc12ae62e00"><gtr:id>f095c2a425effc4410c61fc12ae62e00</gtr:id><gtr:otherNames>Soiza RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>B0AB9B43704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25ADAE18-63E3-4ED6-B071-A8F7FD9383B5</gtr:id><gtr:title>Anticholinergic activity in cerebrospinal fluid and serum in individuals with hip fracture with and without delirium.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e524ebcb7bdec201604566cce3fc381"><gtr:id>5e524ebcb7bdec201604566cce3fc381</gtr:id><gtr:otherNames>Watne LO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn><gtr:outcomeId>56e02f2ca720d3.54742484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85E352D2-58C3-4E0F-A795-4040370A43B2</gtr:id><gtr:title>Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1? in delirium after hip fracture.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/473e4d369d1316f02aea15c367b43532"><gtr:id>473e4d369d1316f02aea15c367b43532</gtr:id><gtr:otherNames>Cape E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>doi_55f9459452a8e1e9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0251BC1-57D0-4E07-8D96-118CD2D10101</gtr:id><gtr:title>Challenges and opportunities in understanding dementia and delirium in the acute hospital.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aae0042fa854117fec20bb47e0207efe"><gtr:id>aae0042fa854117fec20bb47e0207efe</gtr:id><gtr:otherNames>Jackson TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5aa80b69bfeab4.59535266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>486A159E-1838-4D76-B12E-019017383E35</gtr:id><gtr:title>Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82a2f25a3c494f144b9fe7aac6f1374f"><gtr:id>82a2f25a3c494f144b9fe7aac6f1374f</gtr:id><gtr:otherNames>Maclullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>8C73F58AD24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5629DFC2-7E6A-4204-8188-F36506ED7516</gtr:id><gtr:title>Understanding barriers to delirium care: a multicentre survey of knowledge and attitudes amongst UK junior doctors.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c8c78ef79a6c5af275104b65fc05b3d"><gtr:id>2c8c78ef79a6c5af275104b65fc05b3d</gtr:id><gtr:otherNames>Davis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>6B8FE47859D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE49E4BC-B33E-476E-A144-23AF2FFCF219</gtr:id><gtr:title>A comparison of the revised Delirium Rating Scale (DRS-R98) and the Memorial Delirium Assessment Scale (MDAS) in a palliative care cohort with DSM-IV delirium.</gtr:title><gtr:parentPublicationTitle>Palliative &amp; supportive care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/513ae60bb6f26ec90fd9971347e67161"><gtr:id>513ae60bb6f26ec90fd9971347e67161</gtr:id><gtr:otherNames>O'Sullivan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1478-9515</gtr:issn><gtr:outcomeId>56e02f2b62b930.32454963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D060D21-D24C-4F3B-9EAF-AA808CD8173D</gtr:id><gtr:title>Diabetes and cognitive decline: are steroids the missing link?</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ff22e1adc692f91cc17db244a90af"><gtr:id>038ff22e1adc692f91cc17db244a90af</gtr:id><gtr:otherNames>MacLullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>9DB7522C70C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A06288A-3FD2-4A29-BE45-4A975F7C7ADB</gtr:id><gtr:title>Cerebrospinal fluid ?-amyloid and tau are not associated with risk of delirium: a prospective cohort study in older adults with hip fracture.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3095e2db13551903c852e7be0f2dd271"><gtr:id>3095e2db13551903c852e7be0f2dd271</gtr:id><gtr:otherNames>Witlox J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn><gtr:outcomeId>kh2qfwMuwzA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47B0B575-E3A8-4D84-AAE1-A8867D814322</gtr:id><gtr:title>Tract shape modelling provides evidence of topological change in corpus callosum genu during normal ageing.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdf16d3b02102b8cb6f8feda785464b"><gtr:id>bcdf16d3b02102b8cb6f8feda785464b</gtr:id><gtr:otherNames>Bastin ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>238DDDCA55F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EBBACA7-D118-47B6-ADD1-28E6C7F2E0A3</gtr:id><gtr:title>Differential effects of delirium on fluid and crystallized cognitive abilities.</gtr:title><gtr:parentPublicationTitle>Archives of gerontology and geriatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d41c319558c06c88080ce895c5a59196"><gtr:id>d41c319558c06c88080ce895c5a59196</gtr:id><gtr:otherNames>Brown LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0167-4943</gtr:issn><gtr:outcomeId>Xp9UWMRc4gf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A9E96A-DB9E-4DF0-882B-2DF80EF5BF97</gtr:id><gtr:title>Quantitative proteomics of delirium cerebrospinal fluid.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461452f19e3f0a81450ed76100ae39d2"><gtr:id>461452f19e3f0a81450ed76100ae39d2</gtr:id><gtr:otherNames>Poljak A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>56e02f2d41eb86.23432311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>236199A5-20CA-4F0E-AE55-98219A1B2937</gtr:id><gtr:title>A systematic literature review of cerebrospinal fluid biomarkers in delirium.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61873e852dfee4934a7fbcc4598ec8fd"><gtr:id>61873e852dfee4934a7fbcc4598ec8fd</gtr:id><gtr:otherNames>Hall RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>BYvys46BN4V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED7390C6-0C74-4230-B259-7DBA3749F185</gtr:id><gtr:title>Subjective memory complaints and cognitive impairment in older people.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e1fa67fd0f86d19c98053465600e5f"><gtr:id>36e1fa67fd0f86d19c98053465600e5f</gtr:id><gtr:otherNames>Reid LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>9848CAC084F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B45CC961-7A52-4116-AB0D-E367744656BE</gtr:id><gtr:title>Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4c8b49fee63504b59a9f6184309ee23"><gtr:id>d4c8b49fee63504b59a9f6184309ee23</gtr:id><gtr:otherNames>Pearson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>ZabLNfb6rHx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3D7201A-1972-461B-9411-4F47343CCC7F</gtr:id><gtr:title>Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdf16d3b02102b8cb6f8feda785464b"><gtr:id>bcdf16d3b02102b8cb6f8feda785464b</gtr:id><gtr:otherNames>Bastin ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>cqirweR6MyH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F733063F-C21A-4D50-B47B-3DBF96BDFDD7</gtr:id><gtr:title>Detecting deficits of sustained visual attention in delirium.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d41c319558c06c88080ce895c5a59196"><gtr:id>d41c319558c06c88080ce895c5a59196</gtr:id><gtr:otherNames>Brown LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>YQrrS33e3f5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94BF03C8-92FF-4B7C-955F-F2B3161FD91B</gtr:id><gtr:title>11?-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ff22e1adc692f91cc17db244a90af"><gtr:id>038ff22e1adc692f91cc17db244a90af</gtr:id><gtr:otherNames>MacLullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e02f2e4b0129.33164683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1250DA31-D118-4FD7-AA52-D3075F7E4A4F</gtr:id><gtr:title>Tools to detect delirium superimposed on dementia: a systematic review.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a9b6e2bae76c0291107bb0deece9828"><gtr:id>0a9b6e2bae76c0291107bb0deece9828</gtr:id><gtr:otherNames>Morandi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn><gtr:outcomeId>pm_16128_28_23039270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1615310-7708-4790-917C-39908BD3B4FA</gtr:id><gtr:title>The epidemiology of delirium: challenges and opportunities for population studies.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd90d7e6a9c3fcc788b23c038379b1c9"><gtr:id>cd90d7e6a9c3fcc788b23c038379b1c9</gtr:id><gtr:otherNames>Davis DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>pm_16128_28_23907068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44FD3A18-D6B0-4139-969A-6F47C1E522A5</gtr:id><gtr:title>Delirium and long-term cognitive impairment.</gtr:title><gtr:parentPublicationTitle>International review of psychiatry (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ff22e1adc692f91cc17db244a90af"><gtr:id>038ff22e1adc692f91cc17db244a90af</gtr:id><gtr:otherNames>MacLullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-0261</gtr:issn><gtr:outcomeId>803E54B2FF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2FFEF01-B0B4-4BBE-9F6D-327341099ADC</gtr:id><gtr:title>The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC geriatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c5d620c8a8cff15295e1bf8bbd81db"><gtr:id>67c5d620c8a8cff15295e1bf8bbd81db</gtr:id><gtr:otherNames>Neerland BE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2318</gtr:issn><gtr:outcomeId>56e02f2a6131c0.59944539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F059E820-9AE1-40F3-80B3-A6784DC80AA4</gtr:id><gtr:title>Symptoms of depression and delirium assessed serially in palliative-care inpatients.</gtr:title><gtr:parentPublicationTitle>Psychosomatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb9c821290fefb3ff407bf2c825630bd"><gtr:id>eb9c821290fefb3ff407bf2c825630bd</gtr:id><gtr:otherNames>Leonard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-3182</gtr:issn><gtr:outcomeId>7ED0B0E37B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>613CAE6E-6D0D-4FF6-9118-1244BB5DB7F9</gtr:id><gtr:title>Development and initial testing of normal reference MR images for the brain at ages 65-70 and 75-80 years.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bef21d1b805942747b4c7a28da082a1"><gtr:id>6bef21d1b805942747b4c7a28da082a1</gtr:id><gtr:otherNames>Farrell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>5E0689DCEE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B68B7CA9-6DF3-45EF-AB48-C0B87781907B</gtr:id><gtr:title>Smaller left anterior cingulate cortex volumes are associated with impaired hypothalamic-pituitary-adrenal axis regulation in healthy elderly men.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ff22e1adc692f91cc17db244a90af"><gtr:id>038ff22e1adc692f91cc17db244a90af</gtr:id><gtr:otherNames>MacLullich AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>04A0FF9B915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B3B5037-D6EA-413C-B18D-9FC33D1292F3</gtr:id><gtr:title>New waves of delirium understanding.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76488066107a798a86753e6bae06f29f"><gtr:id>76488066107a798a86753e6bae06f29f</gtr:id><gtr:otherNames>Teodorczuk A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn><gtr:outcomeId>5aa80b69366611.25529820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F481CEA1-28A8-40A6-AED6-D53C1CF5ACE7</gtr:id><gtr:title>Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c27435cca9bff5c5d01622aaa2d4fd94"><gtr:id>c27435cca9bff5c5d01622aaa2d4fd94</gtr:id><gtr:otherNames>Westhoff D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>pm_16128_28_24093540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68EE1D3A-92F5-4960-9140-7F3B7A3A68E5</gtr:id><gtr:title>The neuropsychology of delirium: advancing the science of delirium assessment.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b45a9589f96d944ada1dc9c62016d276"><gtr:id>b45a9589f96d944ada1dc9c62016d276</gtr:id><gtr:otherNames>Tieges Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn><gtr:outcomeId>5aa80b69f02a66.29078732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3B379E-22B9-43CA-A182-26A6DFAEE10D</gtr:id><gtr:title>CSF biomarkers in delirium: a systematic review.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61873e852dfee4934a7fbcc4598ec8fd"><gtr:id>61873e852dfee4934a7fbcc4598ec8fd</gtr:id><gtr:otherNames>Hall RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn><gtr:outcomeId>5aa80b698d5990.56872652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D0D3F79-3898-40CF-B8A6-76DBDF0D7C4A</gtr:id><gtr:title>Cognitive assessment of older people.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd9dc19f58376ec7ea99cac38db7a810"><gtr:id>dd9dc19f58376ec7ea99cac38db7a810</gtr:id><gtr:otherNames>Young J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>CH5MfyHnRYe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12A5E524-0630-450D-A489-869D739D8051</gtr:id><gtr:title>Quantitative and qualitative measures of hippocampal atrophy are not correlated in healthy older men.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimaging : official journal of the American Society of Neuroimaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286d9d10e8a355bf57c4ad8c01726127"><gtr:id>286d9d10e8a355bf57c4ad8c01726127</gtr:id><gtr:otherNames>Ferguson KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1051-2284</gtr:issn><gtr:outcomeId>3AA4284ECDD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226D09AE-EB97-4848-A69F-7D311AD96583</gtr:id><gtr:title>Defining delirium for the International Classification of Diseases, 11th Revision.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fc4c667e1ef6707912d6d0a814877dc"><gtr:id>6fc4c667e1ef6707912d6d0a814877dc</gtr:id><gtr:otherNames>Meagher DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>7152FEB41D6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/646</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>